Cardio Diagnostics Holdings/$CDIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cardio Diagnostics Holdings
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
Ticker
$CDIO
Sector
Primary listing
Employees
16
Headquarters
Website
CDIO Metrics
BasicAdvanced
$5.6m
-
-$3.71
2.23
-
Price and volume
Market cap
$5.6m
Beta
2.23
52-week high
$7.91
52-week low
$0.97
Average daily volume
106k
Financial strength
Current ratio
9.789
Quick ratio
8.463
Long term debt to equity
2.699
Total debt to equity
9.975
Interest coverage (TTM)
-438.08%
Profitability
EBITDA (TTM)
-6.086
Gross margin (TTM)
100.00%
Net profit margin (TTM)
-43,832.49%
Operating margin (TTM)
-43,811.49%
Management effectiveness
Return on assets (TTM)
-44.09%
Return on equity (TTM)
-78.62%
Valuation
Price to revenue (TTM)
222.117
Price to book
0.49
Price to tangible book (TTM)
0.56
Price to free cash flow (TTM)
-0.536
Free cash flow yield (TTM)
-186.66%
Free cash flow per share (TTM)
-3.509
Growth
Revenue change (TTM)
-57.51%
Earnings per share change (TTM)
-60.33%
3-year revenue growth (CAGR)
149.89%
3-year earnings per share growth (CAGR)
-56.57%
CDIO News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cardio Diagnostics Holdings stock?
Cardio Diagnostics Holdings (CDIO) has a market cap of $5.6M as of May 04, 2026.
What is the P/E ratio for Cardio Diagnostics Holdings stock?
The price to earnings (P/E) ratio for Cardio Diagnostics Holdings (CDIO) stock is 0 as of May 04, 2026.
Does Cardio Diagnostics Holdings stock pay dividends?
No, Cardio Diagnostics Holdings (CDIO) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Cardio Diagnostics Holdings dividend payment date?
Cardio Diagnostics Holdings (CDIO) stock does not pay dividends to its shareholders.
What is the beta indicator for Cardio Diagnostics Holdings?
Cardio Diagnostics Holdings (CDIO) has a beta rating of 2.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.